Latest Pharmaceuticals News
Erleada’s Phase II Apa-RP trial showed promise in treating high-risk localized prostate cancer patients who previously underwent radical prostatectomy
Key findings include a 100% 24-month postoperative biochemical recurrence-free rate in patients…
FDA accepts Bristol-Myers Squibb’s biologics license application for subcutaneous Opdivo in all previous indications
Acceptance of the application is based on encouraging results from the Phase…
Pharma Pulse 5/8/24: 5 facts to know about HIV PrEP, OpenAI releases ‘deepfake’ detector and more
The latest news for those in the pharmaceutical industry.
From identity to margin: securing audience measurement in pharmaceutical marketing
The industry needs to find a way to balance consumer privacy with…
Planning for the unique challenges faced by cell and gene therapy developers
In an interview with Pharm Exec Associate Editors Don Tracy and Melissa…
FDA approves Azurity Pharmaceuticals’ Myhibin as an oral suspension for organ transplant recipients
Mihibin is reportedly the first FDA-approved liquid formulation of mycophenolic acid, an…